Still no thanks.
Novavax’s efficacy rate is on par with the two-dose mRNA-based vaccines made by Pfizer-BioNTech and Moderna and significantly higher than Johnson & Johnson’s one-dose vaccine. But Novavax’s protein-based shots are cheaper and easier to store than its mRNA counterparts, making it an ideal vaccine for developing countries that are struggling to get the pandemic under control. Novavax’s vaccine also requires two shots injected three weeks apart.
Novavax’s efficacy rate is on par with the two-dose mRNA-based vaccines made by Pfizer-BioNTech and Moderna and significantly higher than Johnson & Johnson’s one-dose vaccine. But Novavax’s protein-based shots are cheaper and easier to store than its mRNA counterparts, making it an ideal vaccine for developing countries that are struggling to get the pandemic under control. Novavax’s vaccine also requires two shots injected three weeks apart.
Seems to be a fairly clear statement that this is not an mRNA based vaccine. IIRC, they produce the antigen in moth cells that have been altered to produce it.
Perhaps that's not what you meant though.